Optimal Strategy of Primary PCI for Left Main Coronary Artery Occlusion Induced AMI (OPTIMAL)
Primary Purpose
Acute Myocardial Infarction, Percutaneous Coronary Intervention
Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Deferred stent implantation
Immediate stent implantation
Sponsored by
About this trial
This is an interventional treatment trial for Acute Myocardial Infarction focused on measuring acute myocardial infarction, percutaneous coronary intervention, deferred stent implantation
Eligibility Criteria
Inclusion Criteria:
- Clinical diagnosis of acute myocardial infarction occured within 12 hours
- Left main coronary artery occlusion confirmed by angiography
- Left main coronary artery occlusion (TIMI flow 0,1 or 2) confirmed by primary angiography, TIMI flow grade 3 achieved after pretreatment of thrombus aspiration or balloon dilatation
Exclusion Criteria:
- Life expectancy less than 1 years
- Cardiogenic shock
- Chronic kidney disease, stage 4 by KDOQI(GFR<30ml/min)
- Contraindications to aspirin or other anti-platelet drugs
- Allergy to contrast agent, rapamycin or paclitaxel
- Patients who are included in other ongoing trials
- Pregnant female
Sites / Locations
- Zhongshan HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Deferred stent implantation
Immediate stent implantation
Arm Description
Drug-eluting stents are implanted 4-10 days after primary angiography and restoration of blood flow in left main coroanry artery in a secondary PCI
Drug-eluting stents are implanted immediately after primary angiography and restoration of blood flow in left main coroanry artery
Outcomes
Primary Outcome Measures
Composite of cardiac death and recurrent myocardial infarction
Recorded in follow-up
Secondary Outcome Measures
All cause death, cardiac death, recurrent myocardial infarction, target vessel revascularization
Recorded in follow-up
Residual stenosis of left main coronary artery
Measured through angiography
Left ventricular ejection fraction
Measured through echocardiogram
Full Information
NCT ID
NCT03282773
First Posted
September 10, 2017
Last Updated
November 18, 2017
Sponsor
Shanghai Zhongshan Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03282773
Brief Title
Optimal Strategy of Primary PCI for Left Main Coronary Artery Occlusion Induced AMI
Acronym
OPTIMAL
Official Title
Optimal Strategy of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction Due to Unprotected Left Main Coronary Artery Occlusion
Study Type
Interventional
2. Study Status
Record Verification Date
November 2017
Overall Recruitment Status
Unknown status
Study Start Date
November 1, 2017 (Actual)
Primary Completion Date
December 31, 2021 (Anticipated)
Study Completion Date
July 31, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Shanghai Zhongshan Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study will compare clinical outcomes of immediate stent implantation with deferred stent implantation(4-10days after primary angiography) for patients presented with acute myocardial infarction due to left main coronary artery occlusion.
Detailed Description
Primary percutaneous coronary intervention for patients presented with acute myocardial infarction caused by left main coronary artery occlusion is associated with significantly higher mortality and risks of major cardiac adverse events. Deferred stent implantation may improve prognosis of primary PCI through reducing distal embolization and no-reflow phenomenon. There is no randomized clinical trial focuses on the effect and outcome of deferred stent implantation on primary PCI for left main coronary artery occlusion in contrast with conventional strategy.
This prospective, multicenter, randomized trial is aimed to compare immediate stenting with deferred stenting for LM-AMI with 30 centers in China involved. We hope to determine whether deferred stenting is superior to conventional strategy for primary PCI of AMI caused by left main coronary artery occlusion in improving long-term clinical outcomes and cardiac function.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Myocardial Infarction, Percutaneous Coronary Intervention
Keywords
acute myocardial infarction, percutaneous coronary intervention, deferred stent implantation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
480 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Deferred stent implantation
Arm Type
Experimental
Arm Description
Drug-eluting stents are implanted 4-10 days after primary angiography and restoration of blood flow in left main coroanry artery in a secondary PCI
Arm Title
Immediate stent implantation
Arm Type
Active Comparator
Arm Description
Drug-eluting stents are implanted immediately after primary angiography and restoration of blood flow in left main coroanry artery
Intervention Type
Device
Intervention Name(s)
Deferred stent implantation
Intervention Description
Primary angiography and pretreatment including balloon dilatation and thrombus aspiration, second generation drug-eluting stents are implanted 4-10 days after restoration of blood flow in left main coronary artery in a secondary PCI.
Intervention Type
Device
Intervention Name(s)
Immediate stent implantation
Intervention Description
Primary angiography and pretreatment including balloon dilatation and thrombus aspiration, second generation drug-eluting stents are implanted immediately after restoration of blood flow in left main coronary artery in a secondary PCI.
Primary Outcome Measure Information:
Title
Composite of cardiac death and recurrent myocardial infarction
Description
Recorded in follow-up
Time Frame
30 days after primary angiography
Secondary Outcome Measure Information:
Title
All cause death, cardiac death, recurrent myocardial infarction, target vessel revascularization
Description
Recorded in follow-up
Time Frame
30 days after primary angiography
Title
Residual stenosis of left main coronary artery
Description
Measured through angiography
Time Frame
Immediately after stent implantation and 12 months after primary angiography
Title
Left ventricular ejection fraction
Description
Measured through echocardiogram
Time Frame
30 days and 12 months after primary angiography
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinical diagnosis of acute myocardial infarction occured within 12 hours
Left main coronary artery occlusion confirmed by angiography
Left main coronary artery occlusion (TIMI flow 0,1 or 2) confirmed by primary angiography, TIMI flow grade 3 achieved after pretreatment of thrombus aspiration or balloon dilatation
Exclusion Criteria:
Life expectancy less than 1 years
Cardiogenic shock
Chronic kidney disease, stage 4 by KDOQI(GFR<30ml/min)
Contraindications to aspirin or other anti-platelet drugs
Allergy to contrast agent, rapamycin or paclitaxel
Patients who are included in other ongoing trials
Pregnant female
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Feng Zhang, M.D.
Phone
13917149007
Email
zhang.feng@zs-hospital.sh.cn
First Name & Middle Initial & Last Name or Official Title & Degree
Yang Gao, M.D.
Phone
18801970322
Email
gysc20@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Junbo Ge, M.D.
Organizational Affiliation
Zhongshan Hospital,Shanghai
Official's Role
Principal Investigator
Facility Information:
Facility Name
Zhongshan Hospital
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
200032
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Feng Zhang, M.D.
Phone
13917149007
Email
zhang.feng@zs-hospital.sh.cn
First Name & Middle Initial & Last Name & Degree
Yang Gao, M.D.
Phone
18801970322
Email
gysc20@163.com
First Name & Middle Initial & Last Name & Degree
Junbo Ge, M.D.
First Name & Middle Initial & Last Name & Degree
Feng Zhang, M.D.
First Name & Middle Initial & Last Name & Degree
Yang Gao, M.D.
12. IPD Sharing Statement
Citations:
PubMed Identifier
30850023
Citation
Gao Y, Zhang F, Li C, Dai Y, Yang J, Qu Y, Qian J, Ge J; OPTIMAL trial investigators. Optimal strategy of primary percutaneous coronary intervention for acute myocardial infarction due to unprotected left main coronary artery occlusion (OPTIMAL): study protocol for a randomised controlled trial. Trials. 2019 Mar 8;20(1):162. doi: 10.1186/s13063-019-3211-0.
Results Reference
derived
Learn more about this trial
Optimal Strategy of Primary PCI for Left Main Coronary Artery Occlusion Induced AMI
We'll reach out to this number within 24 hrs